With the American Diabetes Association annual meeting a week away, four major diabetes tech companies queued up new partnerships for their devices.

Senseonics Holdings Inc. and Sequel Med Tech LLC revealed plans to develop an automated insulin delivery system using the Eversense one-year, implantable continuous glucose monitoring system to increase flexibility for people with type 1 diabetes.